LONA - Athira Pharma, Inc. News

Discover

LONA

Athira Pharma, Inc.

7.52

10 x 7.30

1 x 7.83

bid

ask

0.02

0.31%

12:37 PM

timesize

Ytd	-0.62%
1y	97.98%

7.50

day range

7.75

4.25

52 week range

11.91

Open	7.64	Prev Close	7.50	Low	7.50	High	7.75	Mkt Cap	29.62M
Vol	6.43K	Avg Vol	0.00	EPS	-25.19	P/E	-0.30	Forward P/E	N/A
Beta	2.04	Short Ratio	N/A	Inst. Own	N/A	Dividend	N/A	Div Yield	N/A
Ex Div Date	N/A	Earning	08-06	50-d Avg	6.75	200-d Avg	6.75	1yr Est	0.00

LONA News

benzinga.com

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Tenon Medical (NASDAQ:TNON) shares increased by 115.8% to $0.76 during Monday's pre-mar

benzinga.com

12 Health Care Stocks Moving In Wednesday's After-Market Session

globenewswire.com

LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit

BOTHELL, Wash., June 04, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage bi

globenewswire.com

LeonaBio to Participate in Upcoming Medical and Industry Meetings in June

BOTHELL, Wash., May 27, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage bio

globenewswire.com

LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update

Advancing Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Modulator, a

globenewswire.com

LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Pet

BOTHELL, Wash., May 07, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage bio

seekingalpha.com

LeonaBio, Inc. (LONA) Discusses Modulation and Combination Strategies in ER-Positive Metastatic Brea

globenewswire.com

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatmen

Management to be Joined by Two Clinical Leaders in the Breast Cancer Field Expected to Complete Enr

benzinga.com

12 Health Care Stocks Moving In Wednesday's Intraday Session

globenewswire.com

LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update

Acquired License to Phase 3 Lasofoxifene Development Program of Novel Selective Estrogen Receptor Mo

defenseworld.net

Contrasting Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME)

Prime Medicine (NASDAQ: PRME - Get Free Report) and Athira Pharma (NASDAQ: LONA - Get Free Report) a

defenseworld.net

Financial Analysis: Prime Medicine (NASDAQ:PRME) & Athira Pharma (NASDAQ:LONA)

Athira Pharma (NASDAQ: LONA - Get Free Report) and Prime Medicine (NASDAQ: PRME - Get Free Report) a

defenseworld.net

Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) Head to Head Analysis

Athira Pharma (NASDAQ: LONA - Get Free Report) and Liminatus Pharma (NASDAQ: LIMN - Get Free Report)

defenseworld.net

Reviewing Athira Pharma (NASDAQ:LONA) & Liminatus Pharma (NASDAQ:LIMN)

Liminatus Pharma (NASDAQ: LIMN - Get Free Report) and Athira Pharma (NASDAQ: LONA - Get Free Report)

defenseworld.net

Prime Medicine (NASDAQ:PRME) and Athira Pharma (NASDAQ:LONA) Head to Head Review

Athira Pharma (NASDAQ: LONA - Get Free Report) and Prime Medicine (NASDAQ: PRME - Get Free Report) a

defenseworld.net

Financial Contrast: Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN)

Liminatus Pharma (NASDAQ: LIMN - Get Free Report) and Athira Pharma (NASDAQ: LONA - Get Free Report)

defenseworld.net

Athira Pharma (NASDAQ:LONA) vs. Prime Medicine (NASDAQ:PRME) Financial Analysis

Athira Pharma (NASDAQ: LONA - Get Free Report) and Prime Medicine (NASDAQ: PRME - Get Free Report) a

defenseworld.net

Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME) Financial Review

Prime Medicine (NASDAQ: PRME - Get Free Report) and Athira Pharma (NASDAQ: LONA - Get Free Report) a

globenewswire.com

LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer

Brings more than 25 years of biopharma business development and corporate strategy expertise Brings

newsfilecorp.com

Queen's Road Capital Announces Investment in ATHA Energy Corp.

Hong Kong, Hong Kong--(Newsfile Corp. - January 13, 2026) - Queen's Road Capital Investment Ltd. (TS

accessnewswire.com

ATHA Energy Announces USD$20 Million Convertible Debenture Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES V

defenseworld.net

Athira Pharma (NASDAQ:ATHA) Insider Martin Javier San Sells 1,644 Shares of Stock

Athira Pharma, Inc. (NASDAQ: ATHA - Get Free Report) insider Martin Javier San sold 1,644 shares of

defenseworld.net

Athira Pharma (NASDAQ:ATHA) CEO Mark James Litton Sells 2,586 Shares

Athira Pharma, Inc. (NASDAQ: ATHA - Get Free Report) CEO Mark James Litton sold 2,586 shares of the